Precise Biometrics announces today that they have partnered with the
Inpeco Group for a 6-month contract, to deploy Precise Match-on-Card™
technology to the Inpeco Group System. This will allow Inpeco Group to
provide a unique link between patient ID and the in-vitro automation
process. The Match-on-Card function would allow the patient ID to be
verified at the point when the sample is taken, which is when blood
vials are labeled and registered in the database.
"We are responsible for developing ways to ensure medical acts are
delivered in the right way and that they are fully monitored," stated
Andrea Pedrazzini, President of the Inpeco Group, which includes Inpeco
TIH (Traceability In Healthcare), engaged in performing the Inpeco
Group's R&D activities. "Precise Biometrics' Match-on-Card solution is a
perfect product for our Group and objectives. Its unique capabilities of
combining smart cards and fingerprints ensures that a patient's data
cannot be tampered with and that it's fully secured throughout the
process, from when the blood is extracted through the testing stage. We
have an accurate account of the patient's ID, associated with the sample
tube itself, and at the same time the patient's privacy is maintained."
With Precise Match-on-Card the fingerprint template is both stored and
matched on the smart card chip. The biometrics serve as PIN and password
replacement, but the solution also makes use of the well-known secure
environment of the chip and eliminates the database, facilitating proof
of identity and making the card a truly personal token.
"Our partnership with Inpeco Group has tremendous growth potential and
we're excited about this new venture. After a successful trial, we
expect to grant Inpeco 3-year exclusivity in the in-vitro testing
automation market because we clearly see the value and expertise they
provide, their great care and investment in R&D activities and their key
role on the further development of automated blood test systems", said
Precise Biometrics' CEO, Thomas Marschall.
How a new U.S. health study is fixing bias in wearable data research